Results 1 to 10 of about 18,378,232 (237)

Flow Resistance Analysis of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis [PDF]

Canadian Journal of Gastroenterology and Hepatology, 2022
Cirrhosis-induced clinically significant portal hypertension (CSPH) is a fatal disease. Early detection of CSPH is vitally important to reduce the patients’ mortality rate.
Yizhe Wang, Luxiang Zhao, Zhuozhao Zheng, Yu Zhang   +3 more
doaj   +3 more sources

Clinically significant portal hypertension assessed by spleen stiffness measurement and its associated outcomes among people living with HIV/AIDS [PDF]

Scientific Reports
People living with HIV/AIDS (PLWHA) are at increased risk of developing portal hypertension, characterized by higher spleen stiffness. This study aimed to evaluate the prevalence of elevated spleen stiffness measurement (SSM) using vibration-controlled ...
Worapong Nasomsong, Patsuda Laukongtam, Sakkarin Chirapongsathorn   +2 more
doaj   +3 more sources

Artificial intelligence for the noninvasive diagnosis of clinically significant portal hypertension

EngMedicine
Cirrhosis is frequently associated with portal hypertension (PH), which can result in severe complications, including varices, ascites, and hepatic encephalopathy.
Zheyu Du, Ling Yang, Hongliang He, Xiaofeng Wu, Xiaolong Qi, Yudong Zhang   +5 more
doaj   +4 more sources

Preliminary quantitative assessment of liver and spleen MR imaging and elastography in clinically significant portal hypertension [PDF]

Scientific Reports
Patients with clinically significant portal hypertension (CSPH) are at high risk of developing severe complications of portal hypertension. The aim of our preliminary study was to assess multiparametric liver and spleen MRI and MR elastography for the ...
Constance de Margerie-Mellon, Florian Joly, Arthur Tenenhaus, Riccardo Sartoris, Valérie Paradis, Maxime Ronot, Pierre-Emmanuel Rautou, Philippe Garteiser, Bernard E. Van Beers   +8 more
doaj   +3 more sources

CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma [PDF]

JHEP Reports, 2023
Background & Aims: Clinically significant portal hypertension (CSPH) is a landmark in the natural history of cirrhosis, influencing clinical decisions in patients with hepatocellular carcinoma (HCC).
Mario Romero-Cristóbal, Ana Clemente-Sánchez, Enrique Ramón, Luis Téllez, Elena Canales, Olga Ortega-Lobete, Elena Velilla-Aparicio, María-Vega Catalina, Luis Ibáñez-Samaniego, Sonia Alonso, Arturo Colón, Ana-María Matilla, Magdalena Salcedo, Agustín Albillos, Rafael Bañares, Diego Rincón   +15 more
doaj   +3 more sources

Ammonia‐to‐Urea Ratio: A Noninvasive First‐Line Tool for Detecting Clinically Significant Portal Hypertension [PDF]

JGH Open
Introduction Cirrhosis progresses from compensated to decompensated phases, often marked by portal hypertension and complications like ascites, variceal hemorrhage, and hepatic encephalopathy.
Hatime Ouahbi, Vincent Haghnejad, Alexia Audouy, Maël Silva Rodriguez, Françoise Barbé, Jean‐Louis Guéant, Jean‐Pierre Bronowicki, Abderrahim Oussalah   +7 more
doaj   +2 more sources

Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension [PDF]

JHEP Reports, 2021
Background & Aims: Liver resection (LR) in patients with hepatocellular carcinoma (HCC) and clinically significant portal hypertension (CSPH) defined as a hepatic venous pressure gradient (HVPG) ≥10 mmHg is not encouraged.
Daniel Azoulay, Emilio Ramos, Margarida Casellas-Robert, Chady Salloum, Laura Lladó, Roy Nadler, Juli Busquets, Celia Caula-Freixa, Kristel Mils, Santiago Lopez-Ben, Joan Figueras, Chetana Lim   +11 more
doaj   +2 more sources

Predictive value of subharmonic-aided pressure estimation for diagnosing clinically significant portal hypertension [PDF]

Scientific Reports
Subharmonic-aided pressure estimation (SHAPE) is an innovative ultrasound-based method using contrast agents to assess the severity of portal hypertension (PH).
Yoshiko Nakamura, Masashi Hirooka, Ryo Yano, Naohisa Kamiyama, Takuma Oguri, Toyoki Shimamoto, Makoto Morita, Yuki Okazaki, Atsushi Yukimoto, Naoki Fukuyama, Takao Watanabe, Teruki Miyake, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa   +15 more
doaj   +2 more sources

Soluble endoglin as a marker of clinically significant portal hypertension in patients with cirrhosis [PDF]

Scientific Reports
Portal hypertension (PH) is one of the major complications of liver cirrhosis, traditionally assessed using invasive methods such as the hepatic venous pressure gradient (HVPG).
Ivone Cristina Igreja Sa, Vaclav Smid, Petra Fikrova, Jana Urbanková Rathouska, Ivana Nemeckova, Katarina Tripska, Adela Diepoltova, SeyedehNiloufar Mohammadi, Ctirad Andrys, Jaromir Petrtyl, Radan Bruha, Libor Vitek, Petr Nachtigal   +12 more
doaj   +2 more sources

A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension [PDF]

BMC Cancer
Objective Clinically significant portal hypertension (CSPH) seriously affects the feasibility and safety of surgical treatment for hepatocellular carcinoma (HCC) patients.
Jia-zhou Ye, Hua-ze Lu, Can Zeng, Guo Lei, Xiao-bo Wang, Jie Chen, Tao Bai, Fei-xiang Wu, Rong-yun Mai, Wei-xing Guo, Le-qun Li   +10 more
doaj   +2 more sources